{
    "organizations": [],
    "uuid": "8f6f56f04531760697977d1d0c6ee65cb8001600",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/27/the-associated-press-acadia-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Acadia reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Tuesday reported a loss of $68.9 million in its fourth quarter.\nThe San Diego-based company said it had a loss of 55 cents per share.\nThe results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.\nThe drugmaker posted revenue of $43.6 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $45.3 million.\nFor the year, the company reported that its loss widened to $289.4 million, or $2.36 per share. Revenue was reported as $124.9 million.\nFor the current quarter ending in April, Acadia said it expects revenue in the range of $45 million to $48 million.\nThe company expects full-year revenue in the range of $255 million to $270 million.\nAcadia shares have climbed roughly 4 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $31.19, a drop of 22 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD",
    "published": "2018-02-28T02:11:00.000+02:00",
    "crawled": "2018-02-28T03:00:06.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "acadia",
        "pharmaceutical",
        "acad",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "per",
        "share",
        "result",
        "surpassed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "six",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "drugmaker",
        "posted",
        "revenue",
        "million",
        "period",
        "falling",
        "short",
        "street",
        "forecast",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "current",
        "quarter",
        "ending",
        "april",
        "acadia",
        "said",
        "expects",
        "revenue",
        "range",
        "million",
        "million",
        "company",
        "expects",
        "revenue",
        "range",
        "million",
        "million",
        "acadia",
        "share",
        "climbed",
        "roughly",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "drop",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "acad",
        "http"
    ]
}